# MCM9

## Overview
The MCM9 gene encodes the minichromosome maintenance 9 homologous recombination repair factor, a protein integral to the maintenance of genomic stability. This protein is a component of the MCM8/9 helicase complex, which is involved in DNA replication and repair, particularly through homologous recombination. MCM9 is characterized by its unique C-terminal domain, which facilitates interactions with other proteins, such as RAD51, crucial for DNA repair processes. The protein's role in stabilizing replication forks and facilitating DNA repair underscores its importance in cellular replication and genomic integrity. Mutations in the MCM9 gene are linked to various clinical conditions, including genomic instability syndromes, early-onset cancers, and reproductive disorders, highlighting its critical function in human health (Goldberg2021MCM9; Griffin2022A; WoodTrageser2014MCM9).

## Structure
The MCM9 protein is characterized by a unique structure within the MCM family, featuring a long C-terminal extension (CTE) that comprises 42% of its total length and is highly disordered (McKinzey2021Motifs). This CTE includes a 'bipartite-like' nuclear localization signal (NLS) and a BRC variant (BRCv) motif, both crucial for its function in DNA repair (McKinzey2021Motifs). The NLS is essential for the nuclear import of the MCM8/9 complex, as MCM8 lacks its own NLS (McKinzey2021Motifs). The BRCv motif is important for interacting with RAD51, facilitating the formation of nuclear foci in response to DNA damage (McKinzey2021Motifs).

Structurally, MCM9 forms part of the MCM8/9 complex, which is a heterohexameric ring with a central channel for DNA passage (Weng2023Structural). The N-terminal domain (NTD) of MCM9, along with MCM8, contributes to the hexameric structure, with a pinwheel-like architecture and a central channel (Li2021Structural). The NTD includes a zinc-finger motif capable of binding both zinc and iron, which may play roles in structural integrity or activity regulation (Li2021Structural). The C-terminal domain (CTD) is more flexible and less defined compared to the NTD (Li2021Structural).

## Function
The MCM9 gene encodes a protein that is a crucial component of the MCM8/9 helicase complex, which plays a significant role in maintaining genomic stability during DNA replication and repair processes. This complex is involved in homologous recombination, a critical mechanism for repairing double-strand breaks in DNA, and is essential for normal replication fork progression and protection of stalled forks during replication stress (Griffin2022A). MCM9, through its helicase activity, aids in the elongation phase of DNA replication and interacts with proteins such as RAD51 to stabilize stalled replication forks, preventing excessive degradation and ensuring proper DNA synthesis (Griffin2022A; Griffin2019The).

MCM9 is characterized by a unique C-terminal domain that facilitates protein-protein interactions necessary for DNA repair, particularly in recruiting factors like RAD51 to sites of DNA damage (Griffin2019The). The MCM8/9 complex is active within the cell nucleus, where it forms nuclear foci upon DNA damage, indicating its role in homologous recombination and fork protection (Griffin2022A). The absence of MCM9 leads to increased genomic instability, slower replication rates, and delayed cell cycle progression, highlighting its essential role in maintaining genome integrity (Griffin2022A).

## Clinical Significance
Mutations in the MCM9 gene are associated with several clinical conditions, primarily due to its role in DNA repair and genomic stability. Pathogenic variants in MCM9 have been linked to a genomic-instability syndrome characterized by premature ovarian failure (POF), short stature, and chromosomal instability. This syndrome is often associated with hypergonadotropic hypogonadism, where the body's ability to produce sex hormones is impaired (WoodTrageser2014MCM9). 

MCM9 mutations also predispose individuals to early-onset cancers, including colorectal and cervical cancers. These mutations can lead to defects in mismatch repair and homologous recombination, contributing to cancer development (Goldberg2021MCM9). In particular, MCM9 is considered a cancer predisposition gene for early-onset colorectal cancer and gynecologic tumors (Goldberg2021MCM9).

In the context of fertility, MCM9 mutations are linked to primary ovarian insufficiency and infertility. In males, mutations can result in severe oligoteratoasthenozoospermia, a condition characterized by low sperm count and poor sperm quality (Goldberg2021MCM9). Additionally, MCM9 polymorphisms have been associated with increased risks of meiotic errors, such as nondisjunction of chromosome 21, which can lead to Down syndrome (Pal2021The). 

Overall, MCM9 plays a critical role in maintaining genomic stability, and its dysfunction can lead to significant reproductive and oncological disorders.

## Interactions
MCM9 is involved in several critical protein-protein interactions essential for DNA repair processes. It forms a complex with MCM8, which is crucial for DNA repair, particularly in homologous recombination (HR) and interstrand cross-link (ICL) repair pathways. MCM9 contains a C-terminal extension (CTE) with a BRC variant (BRCv) motif that directly interacts with RAD51, a key protein in HR. This interaction is vital for recruiting RAD51 to sites of DNA damage, facilitating DNA repair processes such as fork restart or recombination during replication stress (McKinzey2021Motifs).

The MCM9 protein also interacts with HROB, which acts upstream to recruit the MCM8-MCM9 complex to DNA damage sites. This interaction is necessary for the localization of the complex to sites of DNA damage, indicating a role in the control of HR (Hustedt2019Control). Additionally, MCM9 is part of a nuclear interactome that includes various proteins, suggesting its involvement in broader DNA replication and repair networks (Hutchins2016Proteomic). These interactions highlight MCM9's role in maintaining genomic stability through its participation in multiprotein complexes and its interactions with key DNA repair proteins.


## References


[1. (Li2021Structural) Jun Li, Daqi Yu, Lan Liu, Huanhuan Liang, Qi Ouyang, and Yingfang Liu. Structural study of the n-terminal domain of human mcm8/9 complex. Structure, 29(10):1171-1181.e4, October 2021. URL: http://dx.doi.org/10.1016/j.str.2021.05.006, doi:10.1016/j.str.2021.05.006. This article has 11 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.str.2021.05.006)

[2. (Goldberg2021MCM9) Yael Goldberg, Ola Aleme, Lilach Peled-Perets, Sergi Castellvi-Bel, Maartje Nielsen, and Stavit A. Shalev. Mcm9 is associated with germline predisposition to early-onset cancer—clinical evidence. npj Genomic Medicine, September 2021. URL: http://dx.doi.org/10.1038/s41525-021-00242-4, doi:10.1038/s41525-021-00242-4. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41525-021-00242-4)

3. (Weng2023Structural) Structural and mechanistic insights into the MCM8/9 helicase complex. This article has 0 citations.

[4. (Griffin2019The) Wezley C. Griffin and Michael A. Trakselis. The mcm8/9 complex: a recent recruit to the roster of helicases involved in genome maintenance. DNA Repair, 76:1–10, April 2019. URL: http://dx.doi.org/10.1016/j.dnarep.2019.02.003, doi:10.1016/j.dnarep.2019.02.003. This article has 44 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.dnarep.2019.02.003)

[5. (Pal2021The) Upamanyu Pal, Pinku Halder, Anirban Ray, Sumantra Sarkar, Supratim Datta, Papiya Ghosh, and Sujay Ghosh. The etiology of down syndrome: maternal mcm9 polymorphisms increase risk of reduced recombination and nondisjunction of chromosome 21 during meiosis i within oocyte. PLOS Genetics, 17(3):e1009462, March 2021. URL: http://dx.doi.org/10.1371/journal.pgen.1009462, doi:10.1371/journal.pgen.1009462. This article has 6 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1371/journal.pgen.1009462)

[6. (McKinzey2021Motifs) David R. McKinzey, Shivasankari Gomathinayagam, Wezley C. Griffin, Kathleen N. Klinzing, Elizabeth P. Jeffries, Aleksandar Rajkovic, and Michael A. Trakselis. Motifs of the c-terminal domain of mcm9 direct localization to sites of mitomycin-c damage for rad51 recruitment. Journal of Biological Chemistry, 296:100355, January 2021. URL: http://dx.doi.org/10.1016/j.jbc.2021.100355, doi:10.1016/j.jbc.2021.100355. This article has 19 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.jbc.2021.100355)

[7. (WoodTrageser2014MCM9) Michelle A. Wood-Trageser, Fatih Gurbuz, Svetlana A. Yatsenko, Elizabeth P. Jeffries, L. Damla Kotan, Urvashi Surti, Deborah M. Ketterer, Jelena Matic, Jacqueline Chipkin, Huaiyang Jiang, Michael A. Trakselis, A. Kemal Topaloglu, and Aleksandar Rajkovic. Mcm9 mutations are associated with ovarian failure, short stature, and chromosomal instability. The American Journal of Human Genetics, 95(6):754–762, December 2014. URL: http://dx.doi.org/10.1016/j.ajhg.2014.11.002, doi:10.1016/j.ajhg.2014.11.002. This article has 164 citations.](https://doi.org/10.1016/j.ajhg.2014.11.002)

[8. (Hustedt2019Control) Nicole Hustedt, Yuichiro Saito, Michal Zimmermann, Alejandro Álvarez-Quilón, Dheva Setiaputra, Salomé Adam, Andrea McEwan, Jing Yi Yuan, Michele Olivieri, Yichao Zhao, Masato T. Kanemaki, Andrea Jurisicova, and Daniel Durocher. Control of homologous recombination by the hrob–mcm8–mcm9 pathway. Genes &amp; Development, 33(19–20):1397–1415, August 2019. URL: http://dx.doi.org/10.1101/gad.329508.119, doi:10.1101/gad.329508.119. This article has 60 citations.](https://doi.org/10.1101/gad.329508.119)

[9. (Griffin2022A) Wezley C. Griffin, David R. McKinzey, Kathleen N. Klinzing, Rithvik Baratam, Achini Eliyapura, and Michael A. Trakselis. A multi-functional role for the mcm8/9 helicase complex in maintaining fork integrity during replication stress. Nature Communications, August 2022. URL: http://dx.doi.org/10.1038/s41467-022-32583-8, doi:10.1038/s41467-022-32583-8. This article has 11 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-022-32583-8)

[10. (Hutchins2016Proteomic) James R.A. Hutchins, Sabine Traver, Philippe Coulombe, Isabelle Peiffer, Magali Kitzmann, Daniel Latreille, and Marcel Méchali. Proteomic data on the nuclear interactome of human mcm9. Data in Brief, 6:410–415, March 2016. URL: http://dx.doi.org/10.1016/j.dib.2015.11.055, doi:10.1016/j.dib.2015.11.055. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.dib.2015.11.055)